Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to David L. Wyles

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Wyles, David

Item TypeName
Academic Article Development of herpes simplex virus disease in patients who are receiving cidofovir.
Concept DNA, Viral
Concept Drug Resistance, Viral
Concept Hepatitis B virus
Concept Viral Nonstructural Proteins
Concept Hepatitis C Antibodies
Concept Genes, Viral
Concept RNA, Viral
Concept Drug Resistance, Multiple, Viral
Concept Hepatitis, Viral, Human
Concept Hepatitis C
Concept Hepatitis C, Chronic
Concept Hepatitis
Concept Genome, Viral
Concept Viral Proteins
Concept Hepatitis B, Chronic
Concept Viral Load
Academic Article Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Academic Article Hepatitis C virus drug resistance: implications for clinical management.
Academic Article High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen.
Academic Article TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
Academic Article Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Academic Article Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
Academic Article Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.
Academic Article Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.
Academic Article Interferon ?-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
Academic Article Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Academic Article Antiviral resistance and the future landscape of hepatitis C virus infection therapy.
Academic Article Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV).
Academic Article Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.
Academic Article Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.
Academic Article Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection.
Academic Article Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.
Academic Article CROI 2016: Viral Hepatitis and Liver Fibrosis.
Academic Article Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.
Academic Article News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference.
Academic Article High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
Academic Article Functional conservation despite structural divergence in ligand-responsive RNA switches.
Academic Article CROI 2015: Highlights of Viral Hepatitis Therapy.
Academic Article Resistance to DAAs: When to Look and When It Matters.
Academic Article The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care.
Academic Article Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA.
Academic Article Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection.
Academic Article Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.
Academic Article Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.
Academic Article Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.
Academic Article Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
Academic Article Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way more.
Academic Article Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
Academic Article Early identification and linkage to care of persons with chronic hepatitis B virus infection--three U.S. sites, 2012-2014.
Academic Article Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.
Academic Article Moving beyond interferon alfa: investigational drugs for hepatitis C virus infection.
Academic Article CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis.
Academic Article 3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication.
Academic Article Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Academic Article Update on hepatitis C virus resistance to direct-acting antiviral agents.
Academic Article Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir.
Academic Article Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.
Academic Article Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
Academic Article Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir.
Academic Article Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.
Academic Article The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons.
Academic Article The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care.
Academic Article Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model.
Academic Article Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo.
Academic Article Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Academic Article Sofosbuvir for previously untreated chronic hepatitis C infection.
Academic Article Regimens for Patients Coinfected with Human Immunodeficiency Virus.
Academic Article Rong's numbers: accelerating progress in HCV therapeutic research.
Academic Article Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
Academic Article Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
Academic Article A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.
Academic Article All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection.
Academic Article Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Academic Article Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.
Academic Article Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
Grant Analysis of HIV/HCV Sexual Transmission Pairs Using Ultra-Deep Sequencing
Grant The Hepatitis Care Connection Program (Hep-Care Connect)
Grant An in vitro system to study antiviral strategies against Hepatitis C virus
Academic Article CROI 2019: highlights of viral hepatitis.
Academic Article Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease.
Academic Article Primary Incidence of Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men in San Diego, 2000-2015.
Academic Article Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection.
Academic Article Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
Academic Article Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Academic Article Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
Academic Article Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
Academic Article Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Academic Article Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
Academic Article CROI 2018: Highlights of Viral Hepatitis.
Academic Article Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
Academic Article Re-treatment of Hepatitis C Infection After Multiple Failures of Direct-Acting Antiviral Therapy.
Academic Article Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.
Academic Article Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Academic Article Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.

Search Criteria
  • viral
  • hepatitis

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)